TerminatedNCT01454453
Optimisation of Antipsychotic Drug Use in Older People
Medication studyAges 60–95United KingdomSchizophrenia
Understand this study
Who could participate?
Listed age limits: 60 years to 95 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2012
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 64
- Sponsor
- Institute of Psychiatry, London
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom
- Age range
- From 60 Years to 95 Years
- Official registry ID
- NCT01454453
- Official title
Show the full official title
Rationalisation of Antipsychotic Drug Use in Older People, Using [18F]-Fallypride PET
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Institute of Psychiatry, London, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Patients- dose titration.
Who can participate?
Listed age limits: 60 years to 95 years.
Is this study still recruiting?
The registry lists this study as terminated.
